These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12463154)

  • 1. Biocompatibility of DIAPES.
    Bonomini M; Di Stante S; Sirolli V
    Contrib Nephrol; 2003; (138):117-25. PubMed ID: 12463154
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract]   [Full Text] [Related]  

  • 3. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Polaschegg HD
    Hemodial Int; 2006 Apr; 10(2):215-6; author reply 216. PubMed ID: 16623678
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term experience with high-flux polysulfone in hemodialysis.
    Civati G; Teatini U; Guastoni C; Perego A; Perrino ML; Ballerini L; Minetti L
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S26-30. PubMed ID: 7923979
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
    Lonnemann G; Schindler R
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficiency in hemodialysis with polyethersulfone membrane (DIAPES).
    Locatelli F; Di Filippo S; Manzoni C
    Contrib Nephrol; 2003; (138):55-8. PubMed ID: 12463146
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins.
    Krieter DH; Morgenroth A; Barasinski A; Lemke HD; Schuster O; von Harten B; Wanner C
    Nephrol Dial Transplant; 2007 Feb; 22(2):491-9. PubMed ID: 17050637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate removal during dialysis--does the membrane matter?
    Ritz E
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S57-60. PubMed ID: 7923986
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of two different dialysis membranes on leukocyte adhesion and aggregation.
    Hernandez MR; Palomo M; Fuste B; Carbó C; Collado S; Cases A; Escolar G
    Nephron Clin Pract; 2007; 106(1):c1-8. PubMed ID: 17347577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances and innovations in dialysis in the 21st century.
    Power A; Duncan N; Goodlad C
    Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with polysulfone: 10 years.
    Vanholder R; Van Loo A; Ringoir S
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S13-20. PubMed ID: 7923977
    [No Abstract]   [Full Text] [Related]  

  • 13. Dialysis membrane biocompatibility: effects on cellular elements.
    Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
    Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
    Shahbazian H; Zand Moghadam A; Ehsanpour A; Khazaali M
    Iran J Kidney Dis; 2009 Jul; 3(3):151-5. PubMed ID: 19617664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
    Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
    Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Handling of high-permeability DIAPES: practical considerations.
    Potier J
    Contrib Nephrol; 2003; (138):110-6. PubMed ID: 12463153
    [No Abstract]   [Full Text] [Related]  

  • 17. The convertibility of online clearance measurements.
    Schneditz D
    Am J Kidney Dis; 2008 Jul; 52(1):7-9. PubMed ID: 18589214
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymers in dialysis: characteristics and needs.
    Vienken J
    Med Device Technol; 2001; 12(1):18-22, 24, 27. PubMed ID: 11317861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.